Research monograph / questions
Sermorelin: frequently asked questions, answered from the literature.
Direct, cited answers to the questions readers actually ask about sermorelin — definition, mechanism, safety, doping status, and comparisons.
What is sermorelin?
Sermorelin (sermorelin acetate) is a synthetic, amidated 29-amino-acid peptide corresponding to the 1-29 N-terminal fragment of growth hormone-releasing hormone (GHRH) — the shortest fragment that retains full GHRH-receptor activity [1]. Functionally it is a pituitary growth-hormone secretagogue: it prompts the pituitary to release the body's own growth hormone.
What does sermorelin do to the body?
It binds GHRH receptors on anterior-pituitary somatotrophs and activates the cAMP/PKA pathway, stimulating the body's own pulsatile GH release, which in turn raises liver-made IGF-1 [13]. Because it acts upstream on the gland rather than supplying hormone from outside, somatostatin and IGF-1 feedback remain intact, keeping the GH response self-limiting [4].
What is sermorelin used for?
Its historical FDA-approved indication was the evaluation and treatment of growth-hormone deficiency and short stature in children; the branded product was withdrawn from the US market in 2008 for commercial reasons, not safety or efficacy [1][5]. Research has since examined GHRH(1-29) in aging, cognition, sleep, and body composition [6].
Does sermorelin work?
In its approved pediatric use, once-daily subcutaneous GHRH(1-29) accelerated linear growth in GH-deficient children [1]. In older men, 14 days of dosing raised 24-hour GH and IGF-1 [2]. Adult anti-aging efficacy is far less established — an Annals of Internal Medicine editorial called secretagogue use for aging "not yet ready for prime time" [5].
What are the side effects of sermorelin?
Reported effects in the GHRH and secretagogue literature are generally mild — injection-site reactions and flushing — with no fasting-glucose change in the older-men study [2]. The recognized theoretical concern is that chronically raising the mitogens GH and IGF-1 could carry oncologic risk, and long-term adult-use safety data are limited [5].
Why is sermorelin banned in sports?
Growth-hormone secretagogues, including GHRH analogs such as sermorelin, appear on the WADA Prohibited List under hormone and metabolic modulators (S2) and are banned both in- and out-of-competition. Critical reviews classify GHRH-analog peptides among performance-enhancement agents because they raise GH and IGF-1 [8].
Does sermorelin show up on a drug test?
Anti-doping laboratories have developed dedicated detection methods — LC-high-resolution mass spectrometry, dried-blood-spot assays detecting 46 lower-mass doping agents, and IGF-1/GH-2000-score biomarker monitoring that detected GHRH administration in studied subjects [7][9]. Detection remains analytically difficult because the peptides resemble endogenous hormones and clear quickly [8].
Is sermorelin considered safe in the research literature?
Reported effects are generally mild — injection-site reactions and flushing — with no fasting-glucose change in the older-men study [2]. The recognized theoretical concern is that chronically raising the mitogens GH and IGF-1 could carry oncologic risk, and long-term adult-use safety data are limited; an editorial cautioned that secretagogue anti-aging use is not yet established [5].
Does sermorelin affect testosterone?
Sermorelin acts on the GH/IGF-1 axis, not the gonadal axis. The men's-health literature frames GH secretagogues around raising IGF-1 and changing body composition, not raising testosterone [2][6]. No finding in this record shows sermorelin directly increasing testosterone.
Will sermorelin raise my IGF-1 levels?
Yes in studied populations: in older men, 14 days of subcutaneous GHRH(1-29) produced dose-related increases in 24-hour GH and IGF-1 [2], and a related GHRH-analog trial raised IGF-1 by 117% within the physiologic range [6]. The rise stays feedback-regulated rather than supraphysiologic [4].
Does sermorelin build muscle?
There is no sermorelin muscle-hypertrophy trial in this record. GHRH-axis stimulation raises IGF-1, an anabolic mediator [2][6], but reviews note that GH/IGF-1 elevation alone does not reliably translate into functional muscle gains [15] — so muscle-building claims run ahead of the sermorelin-specific evidence.
Is sermorelin effective for weight loss?
There are no controlled sermorelin weight-loss trials. The body-composition signal comes from GHRH-axis stimulation studies — the stabilized analog tesamorelin reducing visceral fat, and pulsatile GH supporting fasting lipolysis — not from sermorelin trials [6][11]. Anti-aging and body-composition marketing outpaces the sermorelin-specific evidence.
Does sermorelin burn fat?
Pulsatile GH secretion contributes to lipolysis in fasting humans, and the stabilized GHRH analog tesamorelin significantly reduced visceral fat in HIV-associated fat accumulation [6][11]. Direct visceral-fat trials of sermorelin itself are lacking; this is class-level GH-axis evidence, not a sermorelin-specific result.
How long does it take for sermorelin to work?
Pharmacokinetic studies show a single dose elevates serum GH for roughly three hours [3]; in the older-men study, dose-related GH and IGF-1 increases were measured over a 14-day course [2]. Timelines beyond these endpoints come from related-analog studies rather than long sermorelin trials.
When is the best time to take sermorelin?
Research protocols used bedtime subcutaneous dosing to coincide with the post-sleep-onset GH pulse, and sleep-endocrine studies show GHRH's effects depend on the time of administration [10][12]. This describes how studies were designed, not a usage recommendation.
Why is it recommended to inject sermorelin at night?
The body's largest endogenous GH pulse occurs shortly after sleep onset, so GHRH research used nocturnal dosing to augment that natural pulse rather than introduce an out-of-phase stimulus [10]. This is described as a studied protocol, not a personal recommendation.
Does sermorelin actually help with sleep, or is it waking me up instead?
GHRH has documented slow-wave-sleep-promoting effects in normal men, but those effects depend on the time of administration [12]. The largest natural GH pulse occurs after sleep onset, which is why bedtime dosing was studied — GHRH given out of phase with that pulse is a different stimulus than GHRH given to augment it.
Is 3 months of sermorelin enough?
Study durations varied widely — from 14-day GH/IGF-1 dosing in older men to a 20-week GHRH-analog cognition trial to year-scale pediatric growth therapy [1][2][6] — so there is no single "enough" window. Outcomes were endpoint- and population-specific, not tied to a fixed duration.
How does sermorelin compare to CJC-1295?
Sermorelin is native GHRH(1-29) with a short (~10-12 min) plasma half-life that preserves pulsatile GH release [3][4]. The brevity of the native peptide motivated longer-acting analogs — the D-Ala2 substitution and the DAC albumin-binding technology behind CJC-1295 — which sustain GH and IGF-1 differently [3]. The /vs-cjc-1295 page covers this in full.
Sermorelin vs ipamorelin: what is the difference?
Sermorelin is a GHRH analog acting on the GHRH receptor; ipamorelin is a growth-hormone-releasing peptide (GHRP) acting on the ghrelin/GHS receptor — a different mechanism within the same somatotropic axis [13][14]. That is why the two are sometimes studied together, and why they are not interchangeable.
How does sermorelin differ from direct HGH injections?
Sermorelin acts upstream on the pituitary to stimulate the body's own pulsatile GH with somatostatin and IGF-1 feedback intact; direct recombinant GH supplies the hormone itself, bypassing that regulation. An editorial argued this physiologic, feedback-preserving approach may differ favorably from supplying exogenous GH directly [4][13].
Does sermorelin affect the brain?
GHRH administration has measurable neuroendocrine effects: a controlled trial reported a favorable effect on cognition in older adults [6], and GHRH has documented effects on slow-wave sleep in normal men [12]. The effects are real in the studied designs but bounded to specific populations and endpoints.
Can sermorelin or GHRH improve cognition in older adults?
In a randomized, placebo-controlled trial of 152 older adults (66 with mild cognitive impairment), 20 weeks of a daily GHRH analog had a favorable effect on cognition (P=0.03) alongside a 117% IGF-1 increase and a 7.4% reduction in percent body fat [6]. The trial used the stabilized analog tesamorelin rather than native sermorelin.